Sucrosomial Iron

Phase 3Small molecule

CCardiochirurgia E.H.

Sucrosomial Iron is one of 94 small molecule programs targeting Iron deficiency anemia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency AnemiaActive, not recruiting

Inflammatory Bowel DiseaseActive, not recruiting

Heart FailureActive, not recruiting

Iron Deficiency AnemiaPhase 3

Active, not recruiting

Inflammatory Bowel DiseasePhase 3

Active, not recruiting

Heart FailurePhase 3

Active, not recruiting

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Sucrosomial Iron

CCardiochirurgia E.H.

Phase 3

2 2

Monoferric

PPharmacosmos A/S

Preclinical

5 3

Zemplar

Savaysa

Coumadin

1 6

Tamiflu

CConrado Roberto Hoffmann Filho

Preclinical

1 7

Oraverse

LLife Extension Foundation Inc.

Preclinical

1 8

Statin

Bristol-Myers Squibb

Preclinical

1 9

Neo-Synephrine

EExela Pharma Sciences, LLC.

Meglitinides

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Heart Failure2 trials

Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency

Unknown status·UUniversity of Padova·Phase 4·NCT05702970·258 enrolled

Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)

Completed·IInstitut de Recerca Biomèdica de Lleida·Phase 3·NCT03833336·72 enrolled

Randomized1 trial

CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery

Completed·CCardiochirurgia E.H.·N/A·NCT03560687·1,023 enrolled

Prospective1 trial

DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron

Not yet recruiting·CCardiochirurgia E.H.·Phase 4·NCT07038330·150 enrolled

Inflammatory Bowel Disease1 trial

Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial

Unknown status·FFondazione IRCCS Policlinico San Matteo di Pavia·Phase 3·NCT04587141·300 enrolled

Donor1 trial

Sucrosomial Iron and Iron Sulphate to Blood Donors

Active, not recruiting·UUppsala University Hospital·N/A·NCT05678647·120 enrolled

1 more indication

Iron deficiency anemia1 trial

Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis

Unknown status·—·Phase 3·NCT05225545·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Sucrosomial Iron. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sucrosomial Iron compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sucrosomial Iron. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cardiochirurgia E.H. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCardiochirurgia E.H.

Sucrosomial Iron

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Heart Failure2 trials

Randomized1 trial

Prospective1 trial

Inflammatory Bowel Disease1 trial

Donor1 trial

Iron deficiency anemia1 trial

References

Drug Info

Quick Facts

Related News